Is a complete GPCR research report available?

No complete published report is available for Structure Therapeutics Inc. (GPCR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · USD

$47.4

-0.54 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GPCR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.4B
Net income (ttm)	-170.3M
EPS (ttm)	-$2.70
Shares out	71.1M
Volume	403,700
Beta	-1.57
Price target	$105	+121.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -170.3M
EPS (ttm): -$2.70
Market cap: 3.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GPCR indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001888886
Company name	Structure Therapeutics Inc.
Country	United States
Country code	US
Cusip	86366E106
Employees	233
Employees Change	50%
Employees Change Percent	27.32
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-02-03
Isin	US86366E1064
Last refreshed	2026-07-30
Market cap	$3.4B
Market cap category	Mid-Cap
Price	$47.35
Price currency	USD
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	GPCR
Website	https://structuretx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.06%
EV Sales Forward	38.25x
FCF yield	-4.73%
P/B ratio	2.33x
PS Forward	67.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-170.3M
Net Income Growth Years	0%
Profit Per Employee	$-731,060
ROA	-11.57
Roa5y	-21.74
ROCE	-14.45
ROE	-15
Roe5y	-34.78
ROIC	-12.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	159.34%
Cagr3y	9.34%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$1.5B
Cash	$1.5B
Current Assets	$1.5B
Current Liabilities	$57M
Debt	$5.8M
Debt Equity	$0
Equity	$1.4B
Liabilities	$61M
Long Term Assets	$17.5M
Long Term Liabilities	$4M
Net Cash	$1.5B
Net Cash By Market Cap	$43.17
Net Cash Growth	75.17%
Net Debt Equity	$-1
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$20.36
WACC	-4.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	26.16
Net Working Capital	$-22.3M
Quick ratio	25.59
Working Capital	$1.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.8%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	159.17%
200-day SMA	51.76
3Y total return	30.73%
50-day SMA	45.55
50-day SMA vs 200-day SMA	50under200
All Time High	94.9
All Time High Change	-50.11%
All Time High Date	2025-12-08
All Time Low	13.22
All Time Low Change	258.17%
All Time Low Date	2025-04-09
ATR	2.57
Beta	-1.57
Beta1y	0.14
Beta2y	0.92
Ch YTD	-31.92
High	48.69
High52	94.9
High52 Date	2025-12-08
High52ch	-50.11%
Low	47
Low52	15.8
Low52 Date	2025-08-06
Low52ch	199.68%
Ma50ch	3.95%
Premarket Change Percent	-2.28
Premarket Price	$46.8
Premarket Volume	4,588
Price vs 200-day SMA	-8.52%
RSI	45.74
RSI Monthly	52.85
RSI Weekly	49.09
Sharpe ratio	1.19x
Sortino ratio	3.75
Total Return	-13.8%
Tr YTD	-31.92
Tr1m	-4.75%
Tr1w	-6.07%
Tr3m	8.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	12
Analyst Price Target Top	$108
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.38
Operating Income	$-219.9M
Price target	$105
Price Target Change	$121
Price Target Change Top	$127

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,913,678%
Float Percent	77.26%
Shares Insiders	3.54%
Shares Institutions	81.42%
Shares Out	71,074,516
Shares Qo Q	14.28%
Shares Yo Y	13.8%
Short Ratio	7.32
Short Shares	11.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-193.9M
Adjusted OCF	-189,448,000
Average Volume	620,097.15x
Bv Per Share	20.36
CAPEX	$-4.5M
Ch1m	-4.75
Ch1w	-6.07
Ch1y	159.2
Ch3m	8.7
Ch3y	30.73
Ch6m	-46.83
Change	-1.13%
Change From Open	0.53
Close	47.89
Days Gap	-1.65
Depreciation Amortization	1,990,000
Dollar Volume	19,115,195
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-209.6M
EBITDA	$-208M
EPS	$-2.7
F Score	2
FCF	$-159.2M
FCF EV Yield	-8.32x
FCF Per Share	$-2.24
Financing CF	759,965,000
Fiscal Year End	December
Founded	2,016
Income Tax	$607,000
Investing CF	-441,184,000
Ipr	215.7
Iprfo	89.4
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	56.08
Ma150ch	-15.57%
Ma20	50.87
Ma20ch	-6.91%
Net CF	164,045,000
Next Earnings Date	2026-08-10
Open	47.1
Optionable	Yes
Position In Range	20.71
Ppne	11,971,000
Pre Close	47.89
Price Date	2026-07-29
Ptbv Ratio	2.33
Relative Volume	0.65x
Share Based Comp	34,712,000
Tr6m	-46.83%
Us State	California
Volume	403,700

Structure Therapeutics Inc. (GPCR)

Coverage state: Market snapshot only — no published research

Generate the first GPCR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · GPCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GPCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GPCR

Frequently asked questions